
Medicine and Health
Targeted delivery of the probiotic *Saccharomyces boulardii* to the extracellular matrix enhances gut residence time and recovery in murine colitis
M. K. Heavey, A. Hazelton, et al.
Discover how engineered *Saccharomyces boulardii* can revolutionize treatment for inflammatory bowel diseases by improving gut residence time and colon concentration. This groundbreaking research was conducted by a team of experts including Mairead K. Heavey and Anthony Hazelton.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.